Company profile for CureLab Oncology

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

CureLab Oncology is a biotechnology company that is developing new anti-cancer biologics.CureLab Oncology is committed to creating a family of revolutionary therapies for oncology patients in order to help prolong their lives.Our lead product, Elenagen, is a plasmid (supercoiled circular DNA) encoding gene p62/SQSTM1. Elenagen reverses tumor grade, changes tumor microenvironment, enhances the anti-cancer effects of other the...
CureLab Oncology is a biotechnology company that is developing new anti-cancer biologics.CureLab Oncology is committed to creating a family of revolutionary therapies for oncology patients in order to help prolong their lives.Our lead product, Elenagen, is a plasmid (supercoiled circular DNA) encoding gene p62/SQSTM1. Elenagen reverses tumor grade, changes tumor microenvironment, enhances the anti-cancer effects of other therapies (e.g. chemotherapy), mitigates chronic inflammation, and stimulates an immune attack on the tumor.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
177 Huntington Ave Fl 17 Boston MA 02115-3156
Telephone
Telephone
1-609-841-1201
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

SCOPE Summit

SCOPE Summit

Not Confirmed

envelop Contact Supplier

SCOPE Summit

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/curelab-oncology-seeks-to-revolutionize-chronic-pain-management-with-novel-p62-based-therapy-302305218.html

PR NEWSWIRE
14 Nov 2024

https://www.prnewswire.com/news-releases/curelab-receives-3m-from-prominent-biotech-investor-dr-john-ballantyne-301760363.html

PR NEWSWIRE
02 Mar 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty